Catalyst Wire Dossier Catalyst Wire Dossier

Nasal live attenuated Bordetella pertussis vaccine

live attenuated intranasal Bordetella pertussis vaccine · Institut National de la Santé et de la Recherche Médicale (INSERM)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nasal live attenuated Bordetella pertussis vaccine, covering 2025-12-10 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine [Phase 1]

See pricing